The JAK2/STAT3 and mitochondrial pathways are essential for quercetin nanoliposome-induced C6 glioma cell death

Cell Death Dis. 2013 Aug 1;4(8):e746. doi: 10.1038/cddis.2013.242.

Abstract

The formulation of quercetin nanoliposomes (QUE-NLs) has been shown to enhance QUE antitumor activity in C6 glioma cells. At high concentrations, QUE-NLs induce necrotic cell death. In this study, we probed the molecular mechanisms of QUE-NL-induced C6 glioma cell death and examined whether QUE-NL-induced programmed cell death involved Bcl-2 family and mitochondrial pathway through STAT3 signal transduction pathway. Downregulation of Bcl-2 and the overexpression of Bax by QUE-NL supported the involvement of Bcl-2 family proteins upstream of C6 glioma cell death. In addition, the activation of JAK2 and STAT3 were altered following exposure to QUE-NLs in C6 glioma cells, suggesting that QUE-NLs downregulated Bcl-2 mRNAs expression and enhanced the expression of mitochondrial mRNAs through STAT3-mediated signaling pathways either via direct or indirect mechanisms. There are several components such as ROS, mitochondrial, and Bcl-2 family shared by the necrotic and apoptotic pathways. Our studies indicate that the signaling cross point of the mitochondrial pathway and the JAK2/STAT3 signaling pathway in C6 glioma cell death is modulated by QUE-NLs. In conclusion, regulation of JAK2/STAT3 and ROS-mediated mitochondrial pathway agonists alone or in combination with treatment by QUE-NLs could be a more effective method of treating chemical-resistant glioma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects*
  • Cell Line, Tumor
  • Cell Shape / drug effects
  • Cell Survival / drug effects
  • Drug Screening Assays, Antitumor
  • Glioma
  • Humans
  • Janus Kinase 2 / metabolism*
  • L-Lactate Dehydrogenase / metabolism
  • Liposomes / chemistry
  • Mitochondria / drug effects
  • Mitochondria / metabolism*
  • Nanocapsules / chemistry
  • Necrosis
  • Particle Size
  • Quercetin / pharmacology*
  • Reactive Oxygen Species / metabolism
  • STAT3 Transcription Factor / metabolism*
  • Signal Transduction
  • Tumor Suppressor Protein p53 / metabolism
  • Tyrphostins / pharmacology

Substances

  • Antineoplastic Agents
  • Liposomes
  • Nanocapsules
  • Reactive Oxygen Species
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • Tyrphostins
  • alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide
  • Quercetin
  • L-Lactate Dehydrogenase
  • JAK2 protein, human
  • Janus Kinase 2